Dr. Pasi Janne talks about a new lung cancer study at ASCO 2012 | Dana-Farber Cancer Institute
by on Friday, June 1st, 2012 | No Comments
Pasi Janne, MD, PhD, Dana-Farber Cancer Institute, talks about a new study being presented at ASCO 2012 involving a clinical trial that shows the success of targeted therapies in one of the most common forms of lung cancers. The results could mean a treatment or place to start for treatment concerning this type of lung cancer.
See the rest here: Dr. Pasi Janne talks about a new lung cancer study at ASCO 2012 | Dana-Farber Cancer Institute